MedPath
HSA Approval

DOCETAXEL ADVAGEN CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/ML

SIN15449P

DOCETAXEL ADVAGEN CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/ML

DOCETAXEL ADVAGEN CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/ML

March 13, 2018

ADVAGEN PTE. LTD.

ADVAGEN PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantADVAGEN PTE. LTD.
Licence HolderADVAGEN PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INFUSION, SOLUTION CONCENTRATE

INTRAVENOUS

Medical Information

L01CD02

docetaxel

Manufacturer Information

ADVAGEN PTE. LTD.

Sichuan Huiyu Pharmaceutical Ltd.

Active Ingredients

Docetaxel Anhydrous

20mg/ml

Docetaxel

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DOCETAXEL ADVAGEN CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/ML - HSA Approval | MedPath